We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/8/2017 15:36 | Thanks football ... tuned in. | hugus maximus | |
09/8/2017 15:34 | is it working? | waterloo01 | |
09/8/2017 15:21 | Anyone connected ? Now ok. | chrisatrdg | |
09/8/2017 11:58 | My thoughts too waterloo01 when I heard it at the AGM - nothing unusual.May get an update question today under the question & answer section. | chrisatrdg | |
09/8/2017 11:12 | Indian summers usually refer to a late summer heat in Sept/Oct. | waterloo01 | |
09/8/2017 07:44 | Looking forward to listening in at 3:30 today.Meanwhile on AIM, Technical observers will likely be eyeing an imminent Cup & Handle completion and hopefully lifting us through resistance in the next few days. There was a small tick-up in volume yesterday....... | tightfist | |
08/8/2017 18:45 | Lol, who can tell though if the DMD treatment proves itself then the £2 share price will be a thing of the past....happy to see a share price of £10 which is possible... | bewise2 | |
08/8/2017 18:01 | bewise2 so it's a 10 bagger from here on in with that £20+ price then | football | |
08/8/2017 15:33 | NASDAQ & AIM looking good today hopefully it will hold. Hoping for some positive information from this Wednesday's conference (3.30 UK Time) - the questions from the floor are usually interesting & gives us an idea as to what others are thinking. | chrisatrdg | |
08/8/2017 08:26 | Observation: Over the past few days the NADAQ has moved solidly up during the trading day (yesterday up toward $14.8 by end of play) then in the last couple of minutes, it slams way back down (yesterday falling well below the opening price) Question: Is there an AIM Market Master type scenario at play on the NASDAQ where the market can be pushed up and down in order for it's controllers to make money? (i.e. In the way that trades aren't reported as they actually happen etc?) | hugus maximus | |
07/8/2017 20:49 | Momentum building stateside now as we approach: A possible cdiff announcement The DMD results Q1! Speculation on Sarepta next move re SMMT! A share price of £20+ would be nice, one can always hope! | bewise2 | |
05/8/2017 11:11 | $15 on the NASDAQ next week then?! | hugus maximus | |
04/8/2017 08:19 | Back to basics - If the current AIM & NASDAQ share price can hold it now makes for a good platform for the next stage i.e £2.50 ASK.Hopefully I am not dreaming but with currently sound science this share must now start to progress if it is going to at all. | chrisatrdg | |
03/8/2017 18:40 | Goodness Hugus that's even more obtuse than my allusion | freedosh | |
03/8/2017 12:08 | RNS out and is about Summit Therapeutics plc Summit Therapeutics To Present At The Canaccord Genuity Growth Conference Oxford, UK, 3 August 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and Clostridium difficile infection, announces that Mr Erik Ostrowski, CFO of Summit, will present a corporate overview at the Canaccord Genuity Growth Conference on 9 August 2017 at 10:30am EDT in Boston, Massachusetts, US. A live audio webcast of the presentation will be available through the Investors section on the Company's website, www.summitplc.com. | football | |
03/8/2017 08:43 | Morning Freedosh ... or: Whatever it is ... it's moving very prettily! | hugus maximus | |
02/8/2017 21:27 | Building the inverted head and shoulders of Notre-Dame | freedosh | |
02/8/2017 21:07 | $14.34(3.02%) days high again | football | |
02/8/2017 14:36 | SMMT on the move again it seems also SRPT?..gla lth's | abergele | |
02/8/2017 09:24 | Solomon's query about the success of Sarepta's rights issue: JUL 25, 2017 | BioCentury EXTRA Sarepta Therapeutics Inc. (NASDAQ:SRPT) proposed to raise $250 million but actually raised $325.1 million through the sale of 7.7 million shares at $42.50. Surely if Summit has even a hint of moderately successful data with DMD P2 24 week results in Q1, it becomes ripe for a takeover? Is this what's currently sustaining interest on the NASDAQ? | hugus maximus | |
31/7/2017 22:34 | The end of July worked out really well ... 'look forward to August & September! | hugus maximus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions